Navigation Links
Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
Date:6/27/2012

SANTA BARBARA, Calif. and ABBOTT PARK, Ill., June 27, 2012 /PRNewswire/ -- Direct Relief International, the global health care company Abbott (NYSE: ABT) and its foundation, the Abbott Fund, today announced that they have reached a major milestone of distributing 20 million rapid HIV tests free of charge to HIV testing and counseling programs serving pregnant women and their families in 43 developing countries. Expanding HIV testing for pregnant women is an essential component in helping to prevent mother-to-child transmission (PMTCT) of HIV, a key focus in the global effort to combat HIV/AIDS.

To facilitate access to HIV testing for PMTCT, Abbott and the Abbott Fund made a commitment in 2002 to donate 20 million rapid HIV tests to programs in Africa and the world's Least Developed Countries. To date, more than 150 partner organizations have participated in the program, serving more than 8,000 health facilities. HIV-positive mothers identified through the program can receive free and convenient therapy to help prevent their child from being infected with HIV. As a result, a minimum of 150,000 new cases of HIV have been averted in infants over the past ten years.*

"Helping pregnant mothers to know their HIV status is a critical step in advancing access to treatment and preventing the transmission of HIV to children," said Katherine Pickus, divisional vice president of Global Citizenship & Policy, Abbott, and vice president, the Abbott Fund. "By donating 20 million rapid HIV tests, we have helped thousands of children to be born without HIV. We are grateful to Direct Relief International and the local-country implementing partners for their work in helping us to reach so many mothers and families across the developing world."

"People who are poor or living in rural areas should have equal access to the benefits of HIV prevention and treatment as those who have the financial means or live in urban areas.  Direct Relief is committed to increasing access to HIV testing, prevention, care, and treatment for people across the world," said Thomas Tighe, President and CEO of Direct Relief.    

Every day, approximately 1,000 children worldwide acquire HIV—over 90 percent are infected through mother-to-child transmission. Rapid HIV tests allow any program in a remote setting to share test results in 15 minutes, regardless of access to lab equipment or electricity. By ensuring pregnant women know their HIV status and enrolling those that are HIV positive in appropriate care and treatment, the HIV transmission rate from mother to child can be reduced to less than 5 percent, according to UNAIDS.

Direct Relief, Abbott and the Abbott Fund will continue to work with existing key implementing organizations in 2012 to provide free rapid HIV testing to pregnant women, as well as spouses and children of pregnant women who are found to be HIV positive.

Globally, there were approximately 1.4 million pregnant women living with HIV in low- and middle- income countries in 2010, according to the World Health Organization (WHO).  The 22 highest affected countries account for 90 percent of the new HIV infections in children. However, progress is being made.  In 2005, only 15 percent of HIV-positive pregnant women in low- and middle-income countries received anti-retroviral therapies for PMTCT; in 2010, that number rose to 48 percent of women in need who received anti-retroviral therapies for PMTCT (WHO).

About Direct Relief International 
Direct Relief International is a leading medical relief organization, active in all 50 U.S. states and 70 countries. It works with more than 1,000 health clinics across the U.S. to assist in emergencies and on an ongoing basis, providing them with free medications for people in need. Direct Relief is among the largest medical suppliers to Haiti in response to the 2010 earthquake, has top charity ratings, including four-star and "top notch" rating from Charity Navigator, and a 100% fundraising efficiency rating from Forbes magazine.

For over a decade, Direct Relief has been distributing medicine and medical supplies to prevent and care for people with HIV.  Direct Relief collaborates with Ministries of Health and nongovernmental organizations to provide an ongoing supply of medical commodities and drugs which are essential for their HIV programs.  Through this extensive network of over 9,000 health facilities in countries throughout Sub-Saharan Africa, Asia, and Latin America, front-line healthcare providers have access to the supplies they need to provide HIV testing, treatment, and support for people living with or at risk of HIV infection.

About Abbott and the Abbott Fund
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries. The Abbott Fund is a philanthropic foundation established by Abbott in 1951. The Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to health care and strengthen communities worldwide. For more information on Abbott or the Abbott Fund, visit www.abbott.com or www.abbottfund.org.

Representatives from Direct Relief, Abbott, and the Abbott Fund are available for print, radio, and broadcast interviews, and have full fiber optic and satellite transmission capability.

* The estimate of more than 150,000 averted cases of HIV is based on the conservative methodology used by PEPFAR and other global donors.  This calculation takes the number of women participating in the testing program who test positive and are referred to treatment, and multiplies this number by 19 percent, which is the estimated effectiveness of single-dose treatment regimens (reducing vertical HIV transmission from 35 percent to 16 percent). According to PEPFAR, this is likely to significantly underestimate the number of averted cases of HIV, as many programs are now using more effective multi-drug regimens for PMTCT.


'/>"/>
SOURCE Abbott
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
2. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
3. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
4. Total Therapeutic Management, Inc. invites directors of quality improvement to learn secrets of provider engagement strategies
5. NHD Hires Ron Cronin as Executive Director
6. ReShape Medical Appoints Robert E. Grant to Board of Directors
7. Bench Internationals Denise (DeeDee) DeMan Elected to SoCalBios Board of Directors
8. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
9. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
10. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
11. Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):